Clinical Trial Update: ACOART BTK RENEW：A Post Market Clinical Study [NA]

View source ↗

Summary

Post-market clinical study for ACOART BTK RENEW is recruiting participants for Peripheral Artery Disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Peripheral Artery Disease

Drugs mentioned

• ACOART BTK RENEW

Snippet

Sponsor: Acotec Scientific Co., Ltd | Conditions: Peripheral Artery Disease | NA | Status: RECRUITING